Document is current
Any future updates will be listed below
-
Authors
Heide, Janna https://orcid.org/0000-0002-3528-1602
Bilecz, Agnes J.
Patnaik, Samarjit https://orcid.org/0000-0002-4265-7620
Allega, Maria Francesca https://orcid.org/0000-0003-0952-8496
Donle, Leonhard
Yang, Kaiting https://orcid.org/0000-0001-9328-5655
Teich, Ethan https://orcid.org/0009-0000-4890-4445
Li, Yan
Lin, Qiaoshan https://orcid.org/0000-0001-7851-6048
Kong, Ke
Liu, Li
Yang, Tae Gyun
Cheng, Ken Chih-Chien
Shrimp, Jonathan H.
Hanson, Quinlin M.
Shen, Min
Sun, Hongmao
Shah, Hardik https://orcid.org/0000-0001-8408-5686
Schweizer, Lisa https://orcid.org/0000-0002-1165-7804
Zawieracz, Katarzyna
Olland, Andrea
White, Andre https://orcid.org/0000-0002-4393-1062
Suto, Robert K.
Alhunayan, Razzaq https://orcid.org/0009-0005-5629-0881
Taşdemir, Medine
Longman, Noa
Liang, Hua https://orcid.org/0000-0001-5512-8595
Mann, Matthias https://orcid.org/0000-0003-1292-4799
Stott, Gordon M. https://orcid.org/0000-0002-9148-6100
Hall, Matthew D. https://orcid.org/0000-0002-5073-442X
Schwörer, Simon
Weichselbaum, Ralph R. https://orcid.org/0000-0002-5643-8939
Piffkó, András https://orcid.org/0000-0001-5300-6594
Lengyel, Ernst https://orcid.org/0000-0001-8624-1507
- License Information
-
More Information
Article History
Received: 22 January 2024
Accepted: 18 June 2025
First Online: 23 July 2025
Competing interests
: J.H., S.P., M.F.A., K.K., L.L., T.G.Y., K.C.-C.C., H. Sun, A.W., J.H.S., Q.M.H., M.S., G.M.S., M.D.H. and E.L. are listed as inventors on a patent application describing NNMT inhibitors filed by the NIH and The University of Chicago. The E.L. laboratory receives research grant funding from Abbvie through the University of Chicago. R.R.W. has stock and other ownership interests with Boost Therapeutics, Immvira, Reflexion Pharmaceuticals, Coordination Pharmaceuticals, Magi Therapeutics and Oncosenescence; he has served in a consulting or advisory role for Aettis, AstraZeneca, Coordination Pharmaceuticals, Genus, Merck Serono, Nano Proteagen, NKMax America and Shuttle Pharmaceuticals; he has received research grant funding from Varian and Regeneron through the University of Chicago; he has received compensation, including travel, accommodations or expense reimbursement from AstraZeneca, Boehringer Ingelheim and Merck Serono. The other authors declare no competing interests.
